title: Effect of different ingredients in traditional Korean medicine for human uterine leiomyoma on normal myometrial and leiomyomal smooth muscle cell proliferation.
abstract: Crude water extracts of 13 traditional Korean medicinal ingredients used for leiomyomal treatment were prepared and used to treat human uterine normal myometrial and leiomyomal cell cultures. All the ingredients inhibited proliferation and altered the morphology of both myometrial and leiomyomal cells. Among the 13 ingredients, n-hexane-, chloroform-, and ethylacetate-soluble fractions were extracted from seven ingredients that potently inhibited cell proliferation in their water extract form. Among these, the ethylacetate-fraction of Phlomis umbrosa and Spatholobus suberectus, and the chloroform-fraction of Curcuma zedoaria and S. suberectus inhibited leiomyomal cell proliferation significantly compared to myometrial cell proliferation. Similarly, immunohistochemical analysis showed the inhibition of transforming growth factor-beta receptor 2 in leiomyomal tissue after treatment with the fractions of the ingredients. Moreover, the chloroform-fraction of C. zedoaria was subfractionated by open column chromatography. Two of the eight subfractions (fractions 6 and 7) potently inhibited cell proliferation in leiomyoma compared to myometrium. Further study will be performed with the goal of isolating specific compounds from two effective subfractions of C. zedoaria, ethylacetate-fraction of P. umbrosa, and the ethylacetate and chloroform-fractions of S. suberectus. The present study may be helpful in developing an alternative remedy to leiomyoma with minimal side-effects compared to the current treatments.
authors.affiliation: Department of Biotechnology, Yeungnam University, Gyeongsan 712-749, Korea.
authors.forename: Prati
authors.initials: P
authors.lastname: Bajracharya
authors.forename: Eun Ju
authors.initials: EJ
authors.lastname: Lee
authors.forename: Dong-Mok
authors.initials: DM
authors.lastname: Lee
authors.forename: Sang Hee
authors.initials: SH
authors.lastname: Shim
authors.forename: Keuk-Jun
authors.initials: KJ
authors.lastname: Kim
authors.forename: Sung Ho
authors.initials: SH
authors.lastname: Lee
authors.forename: Jei Jun
authors.initials: JJ
authors.lastname: Bae
authors.forename: Sang Sik
authors.initials: SS
authors.lastname: Chun
authors.forename: Tae Kyun
authors.initials: TK
authors.lastname: Lee
authors.forename: Seok Hoon
authors.initials: SH
authors.lastname: Kwon
authors.forename: Inho
authors.initials: I
authors.lastname: Choi
mesh_terms: D000328:Adult; D049109:Cell Proliferation / Q000187:drug effects*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007889:Leiomyoma / Q000188:drug therapy* / Q000378:metabolism; D055670:Medicine, Korean Traditional; D008875:Middle Aged; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000378:metabolism; D009215:Myometrium / Q000187:drug effects / Q000378:metabolism; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors; D000077294:Receptor, Transforming Growth Factor-beta Type II; D018125:Receptors, Transforming Growth Factor beta / Q000037:antagonists & inhibitors
chemical_list: D010936:Plant Extracts; D018125:Receptors, Transforming Growth Factor beta; D017346:Protein Serine-Threonine Kinases; D000077294:Receptor, Transforming Growth Factor-beta Type II